💨 Abstract
The withdrawal has been initiated due to a surplus of available updated vaccines since the pandemic. The company had partnered with Oxford University to develop the COVID-19 vaccine, which was sold in India as Covishield and as Vaxzevria in Europe.
Courtesy: theprint.in
Summarized by Einstein Beta 🤖
Suggested
'Exercise your right': Amitabh Bachchan urges people to vote in a quirky way
EU activates rapid response mapping to locate missing Iranian President after helicopter crash
Soccer-Champions Inter snatch draw at Europa League qualifying hopefuls Lazio
Soccer-Klopp encourages fans to embrace future after emotional finale at Liverpool
Soccer-Villarreal's Sorloth scores four in thrilling 4-4 draw with Real Madrid
Soccer-Guardiola's demand for perfection fuels Manchester City hunger
Motor racing-Mercedes in 'no-man's land', says Hamilton
Soccer-Arsenal will "keep knocking" until they win Premier League title - Arteta
Soccer-Zamalek win African Confederation Cup on away goals
Soccer-Garcia brace helps Osasuna win 4-1 at Atletico
Powered by MessengerX.io